OverviewSuggest Edit

Misonix, Inc. specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care, and general surgery procedures. Its innovative, ultrasonic platforms for surgical applications include aspirators for the removal of both soft and hard tissue, instruments for laparoscopic cutting and coagulation, devices for wound cleansing and debridement, products for precision bone cutting and sculpting, and liposuction instrumentation for improving body aesthetics. The Company's portfolio of products are all based upon the unique properties of ultrasound and its ability to differentiate hard and soft tissue for different clinical requirements. 

TypePublic
Founded1959
HQFarmingdale, US
Websitemisonix.com
Employee Ratings2.9

Latest Updates

Employees (est.) (Jun 2019)125(+6%)
Revenue (FY, 2019)$38.8 M(+6%)
Share Price (Jan 2020)$17.6

Misonix Office Locations

Misonix has an office in Farmingdale
Farmingdale, US (HQ)
1938 New Hwy
Show all (1)

Misonix Financials and Metrics

Misonix Revenue

Embed Graph
View revenue for all periods
Misonix's revenue was reported to be $38.85 m in FY, 2019
USD

Revenue (FY, 2019)

38.8m

Gross profit (FY, 2019)

27.3m

Gross profit margin (FY, 2019), %

70.2%

Net income (FY, 2019)

(7.4m)

EBIT (FY, 2019)

(7.4m)

Market capitalization (10-Jan-2020)

269.6m

Closing stock price (10-Jan-2020)

17.6

Cash (30-Jun-2019)

7.8m

EV

263.0m
Misonix's current market capitalization is $269.6 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

15.7m14.8m17.1m22.2m23.1m27.3m36.7m38.8m

Revenue growth, %

30%4%

Cost of goods sold

6.5m7.4m5.9m7.3m7.6m8.2m9.8m11.6m

Gross profit

9.2m7.4m11.1m14.9m15.5m19.1m26.9m27.3m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

3.7m3.6m3.6m4.6m3.5m3.0m3.1m4.1m4.3m4.5m5.6m5.3m5.3m6.0m5.4m6.2m6.0m7.2m7.3m8.3m12.4m9.4m10.2m9.6m

Cost of goods sold

1.8m1.3m1.5m1.8m1.6m1.5m1.3m1.2m1.4m1.6m1.8m1.7m1.8m1.9m1.9m1.9m1.8m2.1m2.2m2.5m2.6m2.8m3.0m2.8m

Gross profit

1.9m2.3m2.1m2.7m1.8m1.5m1.7m2.9m2.9m3.0m3.8m3.6m3.5m4.1m3.6m4.3m4.2m5.1m5.1m5.9m9.8m6.6m7.1m6.8m

Gross profit Margin, %

51%64%59%60%53%51%56%70%67%65%68%69%66%68%66%69%70%71%70%70%79%71%70%71%
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

6.3m5.8m7.0m9.6m9.0m11.6m11.0m7.8m

Accounts Receivable

3.2m3.0m3.8m4.5m5.1m5.2m5.4m

Prepaid Expenses

306.7k387.4k367.8k441.6k918.9k611.6k835.0k

Inventories

4.4m4.0m4.2m4.3m5.8m5.0m5.0m7.4m
USDY, 2019

EV/EBIT

-35.5 x

EV/CFO

-71.4 x

Revenue/Employee

310.8k

Financial Leverage

1.4 x
Show all financial metrics

Misonix Online and Social Media Presence

Embed Graph

Misonix News and Updates

Misonix to Present at 38th Annual J.P. Morgan Healthcare Conference

FARMINGDALE, N.Y., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will participate in the 38th Ann…

Misonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkin

FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today the recent publication of two new large …

Misonix to Report Fiscal 2020 First Quarter Financial Results and Host Conference Call and Webcast on November 7

FARMINGDALE, N.Y., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report its fiscal 2020 first quarter financial result…

Misonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical

FARMINGDALE, N.Y., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it completed its previously announced acquisition of private…

Misonix to Report Fiscal 2019 Fourth Quarter Financial Results and Host Conference Call and Webcast on August 14

FARMINGDALE, N.Y., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report its fiscal 2019 fourth quarter financial resul…

Misonix to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8

FARMINGDALE, N.Y., July 18, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will be participating in the Canaccord Genuity 39th Annual…
Show more

Misonix Frequently Asked Questions

  • When was Misonix founded?

    Misonix was founded in 1959.

  • How many employees does Misonix have?

    Misonix has 125 employees.

  • What is Misonix revenue?

    Latest Misonix annual revenue is $38.8 m.

  • What is Misonix revenue per employee?

    Latest Misonix revenue per employee is $310.8 k.

  • Who are Misonix competitors?

    Competitors of Misonix include Microbot Medical, Bovie Medical and Xtant Medical.

  • Where is Misonix headquarters?

    Misonix headquarters is located at 1938 New Hwy, Farmingdale.

  • Where are Misonix offices?

    Misonix has an office in Farmingdale.

  • How many offices does Misonix have?

    Misonix has 1 office.